Abeona secures cash runway with $155m priority review voucher sale

finance.yahoo.com/news/abeona-secures-cash-runway-155m-112113704.html

In This Article:
US-based Abeona Therapeutics has signed a deal to sell its priority review voucher for $155m, two weeks after picking up approval in the US for its first commercial product.
The biotech company was eligible for the voucher upon securing a rare paediatric disease…

This story appeared on finance.yahoo.com, 2025-05-13 11:21:13.
The Entire Business World on a Single Page. Free to Use →